Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Desney Tan, a ...

Quest Partners LLC raised its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 472.5% during the 3rd quarter, ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of medical devices and cloud-based software for the treatment of sleep ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...

Shares of ResMed Inc. RMD advanced 2.37% to $249.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.30% to 5,987.37 and ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. ResMed Inc., a leader in the healthcare industry, has updated its SEC filings, indicating ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Chief Product Officer at ResMed Inc . (NYSE:RMD), has sold 6,160 shares of the company's common stock, according to a recent SEC filing. The... SAN DIEGO, CA – ResMed Inc . (NYSE:RMD), a medical ...